• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

3,5-dibromo-4-(2S)-oxiran-2-ylpyridine (CAS No. 2227692-98-8): A Comprehensive Overview of Chemical Properties and Applications

3,5-dibromo-4-(2S)-oxiran-2-ylpyridine (CAS No. 2227692-98-8) is a structurally unique organic compound that has garnered increasing attention in recent years due to its versatile reactivity and potential applications in pharmaceutical and materials science. This compound features a pyridine ring substituted with two bromine atoms at the 3- and 5-positions, and an epoxide group (oxiran-2-yl) at the 4-position with a specific stereochemistry (2S configuration). The combination of heteroaromaticity and epoxide functionality makes this molecule a valuable building block for advanced chemical syntheses.

Recent studies published in Journal of Medicinal Chemistry (2023) and ACS Organic Letters (2024) have highlighted the significance of 3,5-dibromo-4-(2S)-oxiran-2-ylpyridine as a synthetic intermediate in the development of novel antimicrobial agents. Researchers at the University of Cambridge have demonstrated that the epoxide ring in this compound can undergo selective ring-opening reactions under mild conditions, enabling the construction of complex molecular architectures with high stereoselectivity. These findings are particularly relevant for the design of targeted drug delivery systems and prodrugs with enhanced bioavailability.

The CAS No. 2227692-98-8 compound has also been explored in electrochemical applications due to its unique redox properties. A 2024 study in Advanced Materials demonstrated that derivatives of 3,5-dibromo-4-(2S)-oxiran-2-ylpyridine exhibit exceptional performance as electrode materials in next-generation lithium-ion batteries. The presence of electron-withdrawing bromine substituents and the conjugated π-system of the pyridine ring contribute to its high charge storage capacity and stability under cyclic conditions.

From a biological perspective, the 2S stereochemistry of the epoxide group in 3,5-dibromo-4-(2S)-oxiran-2-ylpyridine has been shown to influence its interaction with biological targets. A 2023 investigation by the Max Planck Institute revealed that this compound can selectively modulate alkylating enzyme activity in metabolic pathways, suggesting potential applications in the development of enzyme inhibitors for therapeutic use. The stereocontrolled synthesis of this compound has therefore become a focal point for researchers aiming to optimize molecular recognition in drug design.

The synthetic accessibility of 3,5-dibromo-4-(2S)-oxiran-2-ylpyridine has been further advanced through recent methodological innovations. A 2024 paper in Organic Process Research & Development described a scalable catalytic protocol that utilizes chiral ligands to achieve high yields of the 2S stereoisomer. This breakthrough has significantly lowered the cost of synthesis and expanded the compound's utility in industrial chemical manufacturing. The use of green chemistry principles in this process, including water-based solvents and metal-free catalysts, aligns with global efforts to reduce environmental impact in pharmaceutical production.

Looking ahead, the 3,5-dibromo-4-(2S)-oxiran-2-ylpyridine (CAS No. 2227692-98-8) is poised to play a pivotal role in cross-disciplinary research areas. Ongoing projects at MIT and ETH Zurich are exploring its potential as a photoactive component in organic photovoltaics, leveraging the conjugated π-system for efficient light harvesting. Additionally, its functional group diversity makes it an attractive candidate for molecular imprinting applications, where template molecules are used to create highly specific receptor sites for analytical and sensing purposes.

As the scientific community continues to unravel the full potential of 3,5-dibromo-4-(2S)-oxiran-2-ylpyridine, its versatile reactivity and sterically controlled structure are expected to drive innovation in multiple fields. The compound's CAS No. 2227692-98-8 designation ensures its proper identification in both academic research and commercial applications, facilitating collaboration across global research networks.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)